INSTAGE: A Randomized Trial of Nintedanib Plus Sildenafil Versus Nintedanib Alone in Patients with Idiopathic Pulmonary Fibrosis (IPF) and Advanced Lung Function Impairment

被引：0
|
作者：
Kolb, M. R. [1 ]
Wells, A. [2 ,3 ]
Behr, J. [4 ,5 ]
Richeldi, L. [6 ]
Schnaidt, S. [7 ]
Quaresma, M. [7 ,8 ]
Stowasser, S. [7 ]
Raghu, G. [9 ]
Martinez, F. J. [10 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Imperial Coll, Natl Inst Hlth Res Resp Biomed Res Unit, Royal Brompton & Harefield NHS Fdn Trust, London, England
[3] Imperial Coll, Natl Heart & Lung Inst, London, England
[4] Univ Munich LMU, Med Klin & Poliklin 5, Munich, Germany
[5] Asklepios Klin Munchen Gauting, German Ctr Lung Res, Munich, Germany
[6] Univ Cattolica Sacro Cuore, Fdn Policlinico A Gemelli, Rome, Italy
[7] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[8] Heidelberg Univ, Thoraxklin, Ctr Interstitial & Rare Lung Dis, Pneumol & Resp Care Med, Heidelberg, Germany
[9] Univ Washington, Seattle, WA 98195 USA
[10] Weill Cornell Med Coll, New York, NY USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1645
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting
    Santos, Gabriela
    Fabiano, Andre
    Mota, Patricia Caetano
    Rodrigues, Ines
    Carvalho, Diogo
    Melo, Natalia
    Novais-Bastos, Helder
    Alexandre, Andre Terras
    Moura, Conceicao Souto
    Guimaraes, Susana
    Pereira, Jose Miguel
    Carvalho, Andre
    Morais, Antonio
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 83
  • [32] Late Breaking Abstract - Safety of combined pirfenidone (PFD) and nintedanib (NIN) in patients with idiopathic pulmonary fibrosis (IPF)
    Flaherty, Kevin
    Fell, Charlene D.
    Huggins, J. Terrill
    Nunes, Hilario
    Sussman, Robert
    Valenzuela, Claudia
    Petzinger, Ute
    Stauffer, John. L.
    Gilberg, Frank
    Bengus, Monica
    Wijsenbeek, Marlies
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [33] EFFECT OF PIRFENIDONE ON EXERCISE CAPACITY AND DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND MORE ADVANCED LUNG FUNCTION IMPAIRMENT
    Nathan, Steven
    Bradley, Sarah
    Costabel, Ulrich
    Albera, Carlo
    Behr, Juergen
    Wuyts, Wim
    Kirchgaessler, Klaus-Uwe
    Stauffer, John
    Morgenthien, Elizabeth
    Yang, Ming
    Limb, Susan
    Noble, Paul
    CHEST, 2018, 154 (04) : 432A - 433A
  • [34] Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF): Pooled Data from Six Clinical Trials
    Lancaster, L. H.
    Hernandez, P.
    Inoue, Y.
    Wachtlin, D.
    Loaiza, L.
    Conoscenti, C. S.
    Quaresma, M.
    Stowasser, S.
    Richeldi, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [35] BLEEDING RISK IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) ON NINTEDANIB AND CON-CURRENT ANTICOAGULATION OR ANTIPLATELET THERAPY
    Denneny, E. K.
    Vekaria, G.
    Sahota, J.
    Beitverda, L.
    Warner, C.
    Garthwaite, H.
    Heightman, M.
    Booth, H.
    Porter, J. C.
    THORAX, 2019, 74 : A119 - A119
  • [36] Antithrombin III as predictive indicator of survival in idiopathic pulmonary fibrosis (IPF) patients treated with nintedanib: a preliminary study
    Bergantini, Laura
    D'Alessandro, Miriana
    Cameli, Paolo
    Carleo, Alfonso
    Landi, Claudia
    Vietri, Lucia
    Lanzarone, Nicola
    Pieroni, Maria
    Sestini, Piersante
    Bargagli, Elena
    INTERNAL MEDICINE JOURNAL, 2021, 51 (05) : 705 - 711
  • [37] Efficacy and Safety of Nintedanib in US and Non-US Patients With Idiopathic Pulmonary Fibrosis (IPF) in the INPULSIS Trials
    Huggins, John
    Kaye, Mitchell
    Bailes, Zelie
    Esser, Dirk
    Conoscenti, Craig
    Flaherty, Kevin
    CHEST, 2015, 148 (04)
  • [38] Impact of Initiating Nintedanib Earlier Versus Later in Patients Newly Diagnosed with Idiopathic Pulmonary Fibrosis
    Singer, D.
    Bengtson, L. G. S.
    Conoscenti, C. S.
    Anderson, A. J.
    Brekke, L.
    Shetty, S.
    De Andrade, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [39] Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment
    Nathan, Steven D.
    Costabel, Ulrich
    Albera, Carlo
    Behr, Juergen
    Wuyts, Wim A.
    Kirchgaessler, Klaus-Uwe
    Stauffer, John L.
    Morgenthien, Elizabeth
    Chou, Willis
    Limb, Susan L.
    Noble, Paul W.
    RESPIRATORY MEDICINE, 2019, 153 : 44 - 51
  • [40] Gastrointestinal Adverse Events with Nintedanib with Add-On Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (IPF): Further Analyses of INJOURNEY
    Vancheri, C.
    Kreuter, M.
    Richeldi, L.
    Ryerson, C. J.
    Valeyre, D.
    Grutters, J. C.
    Stansen, W.
    Quaresma, M.
    Stowasser, S.
    Wuyts, W. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345